Cargando…

Repopulating hematopoietic stem cells from steady-state blood before and after ex vivo culture are enriched in the CD34(+)CD133(+)CXCR4(low) fraction

The feasibility of ex vivo expansion allows us to consider the steady-state peripheral blood as an alternative source of hematopoietic stem progenitor cells for transplantation when growth factor-induced cell mobilization is contraindicated or inapplicable. Ex vivo expansion dramatically enhances th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lapostolle, Véronique, Chevaleyre, Jean, Duchez, Pascale, Rodriguez, Laura, Vlaski-Lafarge, Marija, Sandvig, Ioanna, Brunet de la Grange, Philippe, Ivanovic, Zoran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165804/ https://www.ncbi.nlm.nih.gov/pubmed/29858385 http://dx.doi.org/10.3324/haematol.2017.183962

Ejemplares similares

Busulfan Administration Flexibility Increases the Applicability of Scid Repopulating Cell Assay in NSG Mouse Model
por: Chevaleyre, Jean, et al.
Publicado: (2013)

Alpha Lipoic-Acid Potentiates Ex Vivo Expansion of Human Steady-State Peripheral Blood Hematopoietic Primitive Cells
por: Debeissat, Christelle, et al.
Publicado: (2022)

α-Tocopherol Attenuates Oxidative Phosphorylation of CD34(+) Cells, Enhances Their G0 Phase Fraction and Promotes Hematopoietic Stem and Primitive Progenitor Cell Maintenance
por: Rodriguez, Laura, et al.
Publicado: (2021)

Normal Hematopoetic Stem and Progenitor Cells Can Exhibit Metabolic Flexibility Similar to Cancer Cells
por: Vlaski-Lafarge, Marija, et al.
Publicado: (2020)

On cancer, stemness, and deep evolutionary homologies
por: Ivanovic, Zoran, et al.
Publicado: (2023)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

CD133 Is a Marker For Long-Term Repopulating Murine Epidermal Stem Cells
por: Charruyer, A, et al.
Publicado: (2012)

Regulatory Crosstalk between Physiological Low O(2) Concentration and Notch Pathway in Early Erythropoiesis
por: Labat, Véronique, et al.
Publicado: (2022)

Viability and intracellular nitric oxide generation in the umbilical cord blood CD34(+)CD133(–) and CD34(+)CD133(+) cell populations exposed to local anaesthetics
por: Kulińska, Karolina I., et al.
Publicado: (2021)

CD271+, CXCR7+, CXCR4+, and CD133+ Stem/Progenitor Cells and Clinical Characteristics of Acute Ischemic Stroke Patients
por: Gójska-Grymajło, Anna, et al.
Publicado: (2018)

Circulating CD133+/–CD34– Have Increased c-MYC Expression in Myeloproliferative Neoplasms
por: Uslu Bıçak, İldeniz, et al.
Publicado: (2023)

Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas
por: Mardani, Azam, et al.
Publicado: (2020)

Blockade of TNFα to Improve Human CD34+ Cell Repopulating Activity in Allogeneic Stem Cell Transplantation
por: Senyuk, Vitalyi, et al.
Publicado: (2019)

Distinct Repopulation Activity in Hu-Mice between CB- and LPB-CD34(＋) Cells by Enrichment of Transcription Factors
por: Han, A-Reum, et al.
Publicado: (2021)

Common molecular pathways involved in human CD133+/CD34+ progenitor cell expansion and cancer
por: Okamoto, Oswaldo Keith, et al.
Publicado: (2007)

CD45(dim)CD34(+)CD38(−)CD133(+) cells have the potential as leukemic stem cells in acute myeloid leukemia
por: Heo, Sook-Kyoung, et al.
Publicado: (2020)

VCAM-1 expression is upregulated by CD34(+)/CD133(+)-stem cells derived from septic patients
por: Patry, Christian, et al.
Publicado: (2018)

PAR1 Expression Predicts Clinical G-CSF CD34(+) HSPC Mobilization and Repopulation Potential in Transplanted Patients
por: Nevo, Neta, et al.
Publicado: (2019)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer
por: Cioffi, Michele, et al.
Publicado: (2015)

Expression of adhesion molecules on CD34+ cells from steady-state bone marrow before and after mobilization and their association with the yield of CD34+ cells
por: Cecyn, Karin Zattar, et al.
Publicado: (2018)

High-titer foamy virus vector transduction and integration sites of human CD34(+) cell–derived SCID-repopulating cells
por: Nasimuzzaman, Md, et al.
Publicado: (2014)

Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients
por: Bogoslovsky, Tanya, et al.
Publicado: (2011)

Circulating CD133(+)VEGFR2(+) and CD34(+)VEGFR2(+) cells and arterial function in patients with beta-thalassaemia major
por: Cheung, Yiu-fai, et al.
Publicado: (2011)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

CD133(+)CXCR4(+ )colon cancer cells exhibit metastatic potential and predict poor prognosis of patients
por: Zhang, Shan-shan, et al.
Publicado: (2012)

Autophagy Targeting and Hematological Mobilization in FLT3-ITD Acute Myeloid Leukemia Decrease Repopulating Capacity and Relapse by Inducing Apoptosis of Committed Leukemic Cells
por: Dupont, Marine, et al.
Publicado: (2022)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

The CD133 and CD34 cell types in human umbilical cord blood have the capacity to produce infectious dengue virus particles
por: Vats, Amrita, et al.
Publicado: (2023)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9
por: Ding, Qiang, et al.
Publicado: (2016)

CD133 Is a Marker of Bioenergetic Stress in Human Glioma
por: Griguer, Corinne E., et al.
Publicado: (2008)

Human cord blood-derived primitive CD34-negative hematopoietic stem cells (HSCs) are myeloid-biased long-term repopulating HSCs
por: Matsuoka, Y, et al.
Publicado: (2015)

Endothelial impairment and bone marrow‐derived CD34(+)/133(+) cells in diabetic patients with erectile dysfunction
por: Murata, Miho, et al.
Publicado: (2012)

Effects of pitavastatin on walking capacity and CD34(+)/133(+) cell number in patients with peripheral artery disease
por: Arao, Kenshiro, et al.
Publicado: (2017)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Endothelial cells from cord blood CD133(+)CD34(+) progenitors share phenotypic, functional and gene expression profile similarities with lymphatics
por: Nguyen, Van Anh, et al.
Publicado: (2009)

Distinctive effects of CD34- and CD133-specific antibody-coated stents on re-endothelialization and in-stent restenosis at the early phase of vascular injury
por: Wu, Xue, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7vjqgr82sb90vkm7vhncgr6a27